A phase IIb randomized control trial of Micronised tissue allografts (AmnioFix®) for the treatment of plantar fasciitis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2017
At a glance
- Drugs DHACM (Primary)
- Indications Plantar fasciitis
- Focus Therapeutic Use
- 02 Aug 2017 According to a MiMedx media release, Based on exceptional interim results, company has submitted a summary results amendment along with a formal request to the FDA for closure and unblinding of its Plantar Fasciitis Phase 2B trial.
- 02 Aug 2017 Interim results published in a MiMedx media release.
- 02 Aug 2017 Status changed from recruiting to active, no longer recruiting, according to a MiMedx media release.